Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Contraindications and Precautions BPC-157 is not recommended during pregnancy or breastfeeding due to lack of safety data in these populations
ARTICLE GHK-Cu modulates 4,000+ genes for younger skin
When to Choose AOD-9604: AOD-9604 is particularly well-suited for individuals seeking selective fat metabolism enhancement without broader hormonal changes, those who have not responded adequately to diet and exercise alone for stubborn fat reduction, individuals who cannot tolerate or are contraindicated for GLP-1 agonists or growth hormone, athletes needing body composition improvement without affecting glucose regulation or hormone levels, and those preferring a well-researched peptide with established safety data from clinical trials
Customize doses according to labs, monitor side effects, and use peptide types supported by research
extensive post-market safety data Advantage : Tirzepatide Liver Fat Reduction# Retatrutide : Significant hepatic fat reduction via glucagon receptor activation (up to 82% reduction) Tirzepatide : Moderate hepatic fat reduction observed in trials Advantage : Retatrutide Dosing Convenience# Retatrutide : Once-weekly subcutaneous injection Tirzepatide : Once-weekly subcutaneous injection with established titration schedule Advantage : Neither (tie) Summary and Verdict# Tirzepatide is the proven choice with FDA approval and extensive clinical data
US$ 25.33
US$ 23.70
US$ 27.82
US$ 23.68
US$ 22.92